Literature DB >> 17084714

RNA interference: mechanisms of action and therapeutic consideration.

Piotr G Rychahou1, Lindsey N Jackson, Buckminster J Farrow, B Mark Evers.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17084714     DOI： 10.1016/j.surg.2006.03.009

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  10 in total

1.  Novel small interfering RNA cotargeting strategy as treatment for colorectal cancer.

Authors:  Joseph D Valentino; Victoria A Elliott; Yekaterina Y Zaytseva; Piotr G Rychahou; W Conan Mustain; Chi Wang; Tianyan Gao; B Mark Evers
Journal:  Surgery       Date:  2012-08       Impact factor: 3.982

2.  Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells.

Authors:  Hung Q Doan; Kanika A Bowen; Lindsey A Jackson; B Mark Evers
Journal:  Anticancer Res       Date:  2009-07       Impact factor: 2.480

3.  PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy.

Authors:  Lindsey N Jackson; Shawn D Larson; Scott R Silva; Piotr G Rychahou; L Andy Chen; Suimin Qiu; Srinivasan Rajaraman; B Mark Evers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-03       Impact factor: 4.052

4.  The effects on cell growth and chemosensitivity by livin RNAi in non-small cell lung cancer.

Authors:  Dong Yuan; Liqun Liu; Huaming Xu; Dayong Gu
Journal:  Mol Cell Biochem       Date:  2008-10-01       Impact factor: 3.396

5.  The effect on cell growth by Wnt1 RNAi in human neuroblastoma SH-SY5Y cell line.

Authors:  Lihong Zhang; Kai Li; Zhibao Lv; Xianmin Xiao; Jicui Zheng
Journal:  Pediatr Surg Int       Date:  2009-09-16       Impact factor: 1.827

6.  Murine portal vein catheterization to analyze liver-directed therapies.

Authors:  Joseph D Valentino; Piotr G Rychahou; W Conan Mustain; Victoria A Elliott; B Mark Evers
Journal:  J Surg Res       Date:  2013-07-17       Impact factor: 2.192

Review 7.  MicroRNAs: control and loss of control in human physiology and disease.

Authors:  Min Li; Christian Marin-Muller; Uddalak Bharadwaj; Kwong-Hon Chow; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

8.  Effectiveness of siRNA uptake in target tissues by various delivery methods.

Authors:  Shawn D Larson; Lindsey N Jackson; L Andy Chen; Piotr G Rychahou; B Mark Evers
Journal:  Surgery       Date:  2007-08       Impact factor: 3.982

9.  Targeted suppression of heme oxygenase-1 by small interference RNAs inhibits the production of bilirubin in neonatal rat with hyperbilirubinemia.

Authors:  Jinyong Wu; Wen Su; Youxin Jin; Yi Shi; Chune Li; Wenwei Zhong; Xuehong Zhang; Zili Zhang; Zhenwei Xia
Journal:  BMC Mol Biol       Date:  2009-08-01       Impact factor: 2.946

10.  Hitting bacteria at the heart of the central dogma: sequence-specific inhibition.

Authors:  Louise Carøe Vohlander Rasmussen; Hans Uffe Sperling-Petersen; Kim Kusk Mortensen
Journal:  Microb Cell Fact       Date:  2007-08-10       Impact factor: 5.328
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.